Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. NSE India Stock Exchange
  5. Sun Pharmaceutical Industries Ltd.
  6. Financials
    SUNPHARMA   INE044A01036

SUN PHARMACEUTICAL INDUSTRIES LTD.

(SUNPHARMA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 1 148 922845 2861 434 3221 847 202--
Entreprise Value (EV)1 1 131 107797 9261 363 2381 757 1861 700 1601 644 119
P/E ratio 43,1x22,5x49,4x27,1x23,6x20,2x
Yield 0,57%0,28%1,25%0,64%0,72%0,88%
Capitalization / Revenue 3,95x2,57x4,28x4,87x4,45x4,04x
EV / Revenue 3,89x2,43x4,07x4,63x4,09x3,59x
EV / EBITDA 17,9x11,4x16,1x17,7x15,4x13,1x
Price to Book 2,77x1,87x3,09x3,60x3,20x2,83x
Nbr of stocks (in thousands) 2 399 3352 399 3352 399 3352 399 276--
Reference price (INR) 479352598770770770
Announcement Date 05/28/201905/27/202005/27/2021---
1 INR in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 290 659328 375334 981379 469415 380457 571
EBITDA1 63 07669 89884 91499 325110 674125 970
Operating profit (EBIT)1 45 54349 37064 11479 30188 99099 908
Operating Margin 15,7%15,0%19,1%20,9%21,4%21,8%
Pre-Tax Profit (EBT)1 38 10250 09627 99482 38296 111112 613
Net income1 26 65437 64929 03865 81177 98790 477
Net margin 9,17%11,5%8,67%17,3%18,8%19,8%
EPS2 11,115,712,128,432,638,1
Dividend per Share2 2,751,007,504,895,566,80
Announcement Date 05/28/201905/27/202005/27/2021---
1 INR in Million
2 INR
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3
Net sales1 85 53188 36885 23087 95192 45393 760
EBITDA1 21 93324 06120 48421 64423 40024 500
Operating profit (EBIT)1 16 94718 74214 95016 45617 97818 734
Operating Margin 19,8%21,2%17,5%18,7%19,4%20,0%
Pre-Tax Profit (EBT)1 19 17221 6319 03018 42620 30021 600
Net income1 18 12818 5258 94215 11117 80018 800
Net margin 21,2%21,0%10,5%17,2%19,3%20,1%
EPS2 7,567,723,706,497,277,27
Dividend per Share ------
Announcement Date 11/03/202001/29/202105/27/2021---
1 INR in Million
2 INR
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 17 81447 36071 08590 017147 043203 083
Leverage (Debt / EBITDA) -0,28x-0,68x-0,84x-0,91x-1,33x-1,61x
Free Cash Flow1 -10 16450 12850 00241 23366 39084 790
ROE (Net Profit / Equities) 9,25%8,69%6,33%13,7%14,1%14,6%
Shareholders' equity1 288 069433 368458 667479 615554 781620 384
ROA (Net Profit / Asset) 5,71%5,66%4,27%9,00%10,0%10,7%
Assets1 466 880664 736679 574731 235779 867845 577
Book Value Per Share2 173189194214241272
Cash Flow per Share2 9,1527,325,722,230,133,1
Capex1 32 12815 42011 70118 60217 47916 988
Capex / Sales 11,1%4,70%3,49%4,90%4,21%3,71%
Announcement Date 05/28/201905/27/202005/27/2021---
1 INR in Million
2 INR
Key data
Capitalization (INR) 1 847 202 353 731
Capitalization (USD) 25 070 131 047
Net sales (INR) 334 981 400 000
Net sales (USD) 4 549 047 412
Number of employees 37 000
Sales / Employee (INR) 9 053 551
Sales / Employee (USD) 122 947
Free-Float 82,8%
Free-Float capitalization (INR) 1 529 036 542 782
Free-Float capitalization (USD) 20 752 001 764
Avg. Exchange 20 sessions (INR) 2 500 840 879
Avg. Exchange 20 sessions (USD) 33 961 419
Average Daily Capital Traded 0,14%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA